DSM-Firmenich AG (AMS:DSFIR)
Netherlands
· Delayed Price · Currency is EUR | Market Cap | 15.20B |
| Revenue (ttm) | 9.03B |
| Net Income (ttm) | -1.11B |
| Shares Out | 251.53M |
| EPS (ttm) | -4.27 |
| PE Ratio | 57.35 |
| Forward PE | 18.01 |
| Dividend | 2.50 (4.16%) |
| Ex-Dividend Date | May 8, 2025 |
| Volume | 2,161,526 |
| Average Volume | 1,059,620 |
| Open | 60.36 |
| Previous Close | 60.16 |
| Day's Range | 59.76 - 60.86 |
| 52-Week Range | 58.70 - 103.70 |
| Beta | 0.89 |
| RSI | 38.02 |
| Earnings Date | Feb 12, 2026 |
About DSM-Firmenich AG
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s... [Read more]
Financial Performance
Financial StatementsNews
DSM-Firmenich AG (KDSKF) Q4 2025 Earnings Call Transcript
DSM-Firmenich AG (KDSKF) Q4 2025 Earnings Call Transcript
DSM-Firmenich AG (DSFIY) Shareholder/Analyst Call Transcript
DSM-Firmenich AG (DSFIY) Shareholder/Analyst Call Transcript
DSM-Firmenich AG (KDSKF) Q3 2025 Sales Call Transcript
DSM-Firmenich AG (OTC:KDSKF) Q3 2025 Sales Call October 30, 2025 4:00 AM EDT Company Participants Dave Huizing - Senior Vice President of Investor Relations Dimitri de Vreeze - Chief Executive Officer...
Artisan International Value Fund Q3 2025 Portfolio Update
Major joint customer announcements about new products and significant future orders combined with strong demand for basic memory semiconductors drove renewed interest in Samsung Electronics stock. ABB...
DSM-Firmenich AG (DSFIY) Q2 2025 Earnings Call Transcript
DSM-Firmenich AG (OTCQX:DSFIY) Q2 2025 Earnings Conference Call July 31, 2025 3:00 AM ET Company Participants Dave Huizing - Senior Vice President of Investor Relations Dimitri de Vreeze - Chief Execu...
DSM-Firmenich AG (KDSKF) Q1 2025 Earnings Call Transcript
DSM-Firmenich AG (OTC:KDSKF) Q1 2025 Results Conference Call April 30, 2025 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Ralf Schmeitz - Chief Financial Officer Conference...
DSM-Firmenich AG (KDSKF) Q3 2024 Earnings Call Transcript
DSM-Firmenich AG (OTC:KDSKF) Q3 2024 Earnings Conference Call October 31, 2024 4:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Dimitri de Vreeze - Chief Executive Officer Ral...
DSM-Firmenich AG (KDSKF) Q2 2024 Earnings Call Transcript
DSM-Firmenich AG (OTC:KDSKF) Q2 2024 Earnings Conference Call July 30, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Dimitri de Vreeze - Chief Executive Officer Ralf S...
DSM-Firmenich AG (KDSKF) Q1 2024 Earnings Call Transcript
DSM-Firmenich AG (OTC:KDSKF) Q1 2024 Earnings Conference Call May 2, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Ralf Schmeitz - Chief Financial Officer Conference C...
Royal DSM: Quality At A Price
Royal DSM has proven its resilience through the near-term macro challenges. Its upcoming merger with Firmenich also appears promising and could deliver upside going forward.
Koninklijke DSM N.V. (RDSMY) CEO Geraldine Matchett on Q2 2022 Results - Earnings Call Transcript
Koninklijke DSM N.V. (OTCQX:RDSMY) Q2 2022 Results Conference Call August 2, 2022 8:00 AM ET Company Participants Dave Huizing - Vice President of Investor Relations Geraldine Matchett - Chief Executi...
Health and biotech firm says it has enjoyed resilient demand as health kick is here to stay
Dimitri de Vreeze, co-CEO of DSM, discusses his company's earnings and explains why demand has remained strong.
'A merger of equals': Firmenich CEO Ghostine on DSM deal
Firmenich CEO Gilbert Ghostine describes the company's deal with sector peer DSM as a "merger of equals."
5 Great Green Stocks Making a Direct Impact
It's the end of business as usual. To save the planet, consumers, companies and governments all over the world are stepping up their sustainability game, or at least pledging to do so.
Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript
Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript
DSM co-CEO: Inflationary pressures offset by 4% price increase in some business areas
Geraldine Matchett, co-CEO of DSM and member of CNBC's ESG Council, provides a deep dive into the company's fourth-quarter results and shares how DSM are tackling rising inflation.
Very Confident to Increase Our Outlook: DSM Co-CEO
Aug.04 -- DSM Co-CEO Dimitri de Vreeze discusses the company's earnings, emissions and sustainable foods. He speaks with Bloomberg's Anna Edwards and Mark Cudmore on "Bloomberg: European Market Open".
Koninklijke DSM NV (RDSMY) CEO Dimitri de Vreeze on Q4 2020 Results - Earnings Call Transcript
Koninklijke DSM NV (RDSMY) CEO Dimitri de Vreeze on Q4 2020 Results - Earnings Call Transcript
DSM Going Into 2021 With Positive Momentum, Says Co-CEO
Feb.16 -- Geraldine Matchett, co-chief executive officer at at Dutch Lifesciences company Koninklijke DSM NV, discusses fourth-quarter earnings, the animal nutrition business and her outlook for the b...
Koninklijke DSM N.V. (RDSMY) Dimitri de Vreeze on Q3 2020 Results - Earnings Call Transcript
Koninklijke DSM N.V. (RDSMY) Dimitri de Vreeze on Q3 2020 Results - Earnings Call Transcript
'Analysts failed to see the impact of foreign exchange headwinds on top line,' DSM co-CEO says
Geraldine Matchett and Dimitri de Vreeze, co-CEOs at DSM, discuss the company's third-quarter earnings and the impact of the pandemic on the business.
Koninklijke DSM N.V. (RDSMY) Dimitri Vreeze on Q2 2020 Results - Earnings Call Transcript
Koninklijke DSM N.V. (RDSMY) Dimitri Vreeze on Q2 2020 Results - Earnings Call Transcript
DSM co-CEO's say cash generation 'is a big focus' amid the coronavirus crisis
Geraldine Matchett and Dimitri de Vreeze, co-CEO's of DSM, speak to the corporation's first half of the year along with its strategy amid the uncertainty of a second wave.
Koninklijke DSM NV (RDSMY) Q1 2020 Results - Earnings Call Transcript
Koninklijke DSM NV (RDSMY) Q1 2020 Results - Earnings Call Transcript
Koninklijke DSM N.V. (RDSMY) CEO Feike Sijbesma on Q4 2019 Results - Earnings Call Transcript
Koninklijke DSM N.V. (RDSMY) CEO Feike Sijbesma on Q4 2019 Results - Earnings Call Transcript